LEAP THERAPEUTICS, INC.

Profile

Company Names

LEAP THERAPEUTICS, INC.
DEKKUN CORP

Addresses

47 THORNDIKE STREET, SUITE B1-1, CAMBRIDGE, MA 02142

47 THORNDIKE STREET, SUITE B1-1, CAMBRIDGE, MA 02141

55 CAMBRIDGE PARKWAY, SUITE 102, CAMBRIDGE, MA 02142

Phone Numbers

617 252 4343
617-714-0360

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS, BIOTECHNOLOGY

Year Incorporated:

2011

State Incorporated:

DELAWARE

Total Amount Raised:

$105,149,594.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2023-01-17 
$77,219,193.00 
$77,219,193.00 
$0.00 
Equity 
2
2017-11-14 
$18,000,001.00 
$18,000,001.00 
$0.00 
Equity 
1
2011-01-03 
$9,930,400.00 
$30,500,000.00 
$20,569,600.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JAMES 
 
CAVANAUGH 
DIRECTOR
LEAP THERAPEUTICS, INC.
THOMAS 
 
DIETZ 
DIRECTOR
VIROBAY INC   |  AGBIOME, LLC   |  EIGER BIOPHARMACEUTICALS INC   |  LEAP THERAPEUTICS, INC.
CHRISTINE 
 
GRANFIELD 
EXECUTIVE OFFICER
REVITICELL HOLDINGS, INC.   |  REVITICELL HOLDINGS, LLC   |  LEAP THERAPEUTICS, INC.
AUGUSTINE 
 
LAWLOR 
DIRECTOR, EXECUTIVE OFFICER
GLOBEIMMUNE INC   |  VAXINNATE CORP   |  STEMGENT INC   |  US GENOMICS INC   |  STEMGENT, INC.   |  PATHOGENETIX, INC.   |  CARDIOVASCULAR SYSTEMS INC   |  SHAPE PHARMACEUTICALS, INC.   |  ANEXON, INC.   |  DEKKUN CORP   |  NANOMR, INC.   |  MOSAIC BIOSCIENCES, INC.   |  APOFORE CORP   |  TENSHA THERAPEUTICS, INC.   |  GITR INC.   |  CATALYST BIOSCIENCES INC   |  LEAP THERAPEUTICS, INC.   |  PAINREFORM LTD.   |  LAYERBIO, INC.
WILLIAM 
 
LI 
DIRECTOR
CEAPRO INC.   |  LEAP THERAPEUTICS, INC.
JOHN 
 
LITTLECHILD 
DIRECTOR
CLOUD TECHNOLOGY PARTNERS, INC.   |  LEAP THERAPEUTICS, INC.
JOSEPH 
 
LOSCALZO 
DIRECTOR
N30 PHARMACEUTICALS, INC.   |  LEAP THERAPEUTICS, INC.   |  SCIPHER MEDICINE CORP
PATRICIA 
 
MARTIN 
DIRECTOR
LEAP THERAPEUTICS, INC.   |  AN2 THERAPEUTICS, INC.
NISSIM 
 
MASHIACH 
DIRECTOR
LEAP THERAPEUTICS, INC.   |  MEDIWOUND LTD.
CHRISTOPHER 
 
MIRABELLI 
EXECUTIVE OFFICER, DIRECTOR
THERACLONE SCIENCES, INC.   |  TREVENA INC   |  APOFORE CORP   |  SYNOVEX CORP   |  GALLEON PHARMACEUTICALS INC   |  PROTEOSTASIS THERAPEUTICS, INC.   |  LEAP THERAPEUTICS, INC.   |  ARO BIOTHERAPEUTICS CO
CHRISTOPHER 
K. 
MIRABELLI 
DIRECTOR, EXECUTIVE OFFICER
ASCENT THERAPEUTICS INC   |  ANCHORTHERAPEUTICS, INC   |  ANEXON, INC.   |  DEKKUN CORP   |  PROTEOSTASIS THERAPEUTICS INC   |  PROTEOSTASIS THERAPEUTICS, INC.   |  LEAP THERAPEUTICS, INC.
MARK 
 
O-MAHONY 
EXECUTIVE OFFICER
LEAP THERAPEUTICS, INC.
DOUGLAS 
 
ONSI 
EXECUTIVE OFFICER
SEQUOIA PHARMACEUTICALS INC   |  ANEXON, INC.   |  APELLIS PHARMACEUTICALS, INC.   |  TETRALOGIC PHARMACEUTICALS CORP   |  LEAP THERAPEUTICS, INC.
DOUGLAS 
E. 
ONSI 
EXECUTIVE OFFICER, DIRECTOR
SHAPE PHARMACEUTICALS, INC.   |  DEKKUN CORP   |  APOFORE CORP   |  TENSHA THERAPEUTICS, INC.   |  LEAP THERAPEUTICS, INC.
CHRISTIAN 
 
RICHARD 
DIRECTOR
BIOCLIN THERAPEUTICS, INC.   |  AMPHIVENA THERAPEUTICS, INC.   |  RAINIER THERAPEUTICS, INC.   |  LEAP THERAPEUTICS, INC.   |  SEDARE BIOSCIENCES, INC.
RICHARD 
 
SCHILSKY 
DIRECTOR
LEAP THERAPEUTICS, INC.
CYNTHIA 
 
SIRARD 
EXECUTIVE OFFICER
LEAP THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2023-03-13
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2023-01-17 
2017-11-29
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2017-11-14 
2011-01-07
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2011-01-03 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
RAYMOND JAMES + ASSOCIATES, INC.
705
NONE
NONE
LADENBURG THALMANN + CO. INC.
505
NONE
NONE